SPYRE THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
SPYRE THERAPEUTICS, INC. (SYRE) reported Increase (Decrease) in Deferred Revenue of -$20.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-08
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was $0.00.
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$20.00K.
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$30.00K.
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$51.00K, a 171.83% decline from fiscal 2016.
- SPYRE THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $71.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | -$20.00K 10-Q · filed 2018-11-08 | -$50.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$20.00K 10-Q · filed 2018-08-09 | -$50.00K derived: sum of 3 quarters · filed 2018-08-09 | |
| 2018-03-31 | -$20.00K 10-Q · filed 2018-05-08 | -$50.00K derived: sum of 2 quarters · filed 2018-05-08 | ||
| 2017-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$51.00K 10-K · filed 2018-03-13 | ||
| 2017-09-30 | -$21.00K 10-Q · filed 2018-11-08 | |||
| 2017-03-31 | -$20.00K 10-Q · filed 2018-05-08 | -$130.00K derived: sum of 2 quarters · filed 2018-05-08 | ||
| 2016-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $71.00K 10-K · filed 2018-03-13 | ||
| 2016-09-30 | $181.00K 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |